1-3 of 3
Jill C. Beck
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti-Leukemic Activity of Luveltamab Tazevibulin (LT, STRO-002), a Novel Folate Receptor-α (FR-α)-Targeting Antibody Drug Conjugate (ADC) in Relapsed/Refractory CBF2AT3::GLIS2 AML

Robin Williams, Lane Miller, Stephanie Massaro, Elizabeth Krieger, Melinda Pauly, Catherine Nelson, Rebecca Johnson, Jennifer J.G. Welch, Deepa Bhojwani, Babak Moghimi, Philip Neff, Terzah M. Horton, Hamayun Imran, Raul C. Ribeiro, Terri L. Guinipero, Matthew A. Kutny, Felipe Bautista, Amy Johnson, Karen Lewing, Alan S Gamis, Julienne Brackett, David McCall, Teena Bhatla, Maria Luisa Sulis, Amy Tellinghuisen, Jill C. Beck, Soheil Meshinchi
Journal: Blood
Blood (2023) 142 (Supplement 1): 4295.
https://doi.org/10.1182/blood-2023-180141
Published: 2023
Journal Articles

Outcome of Adolescent & Young Adult (AYA) Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Jill C. Beck, MD, Martin Bast, BS, Deborah A. Perry, MD, Lynette M. Smith, MS, Dennis D. Weisenburger, MD
Journal: Blood
Blood (2012) 120 (21): 1568.
https://doi.org/10.1182/blood.V120.21.1568.1568
Published: 2012
Journal Articles

The TREC to less CMV after UCBT

Jill C. Beck, Michael R. Verneris
Journal: Blood
Blood (2010) 115 (20): 4009–4010.
https://doi.org/10.1182/blood-2010-02-270306
Published: 2010